Year: 2021

EHang Launches 5G Intelligent Air Mobility Experience Center as AAV Operation Spot in GuangzhouCeremony of the 5G Intelligent Air Mobility Experience Center launchEHang Launches 5G Intelligent Air Mobility Experience Center as AAV Operation Spot in GuangzhouThe EH216 AAV’s passenger-carrying flight demo at the 5G Intelligent Air Mobility Experience CenterEHang Launches 5G Intelligent Air Mobility Experience Center as AAV Operation Spot in GuangzhouThe EH216 AAV’s passenger-carrying flight demo at the 5G Intelligent Air Mobility Experience CenterThe 5G Intelligent Air Mobility Experience Center launches in Guangzhou as a new operation spot under EHang’s 100 Air Mobility Routes Initiative. EHang and Guangzhou Development District Communications Investment Group establish a joint venture...

Ewing sarcoma arm advances to second lead-in safety dosing cohort in Sarcoma trial evaluating seclidemstat in combination with chemotherapy agents in patients with relapsed/refractory Ewing sarcoma and as a single-agent therapy in FET-rearranged sarcomas HOUSTON, Dec. 29, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, today announced an important dosing milestone in the Phase 1/2 Sarcoma clinical trial evaluating seclidemstat as a treatment for Ewing sarcoma and other FET-rearranged sarcomas. The trial’s Ewing sarcoma patient arm investigating seclidemstat in combination with chemotherapy agents topotecan and cyclophosphamide (TC) has advanced to the second lead-in safety cohort treating...

BATON ROUGE, La., Dec. 29, 2021 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, Chris Gerard, President and Chief Operating Officer and Scott Ginn, Executive Vice President and Chief Financial Officer will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, at 3:45 p.m. EST. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com. About Amedisys: Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice, personal care and high acuity care services. Amedisys is focused on delivering the care that is best for our patients, whether...

Ji’an, Jiangxi, China, Dec. 29, 2021 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement (the “Agreement”) with Jinggangshan University (“JGSU”), a public university located in Ji’an City of Jiangxi Province, for a study on the chemical constituents of Liparis Odorata, a traditional Chinese medicine, for the treatment of hyperlipidemia. Under the Agreement, JGSU agrees to conduct the aforementioned studies and provide scientific research results to the Company, and report to the Company upon completion within 24 months from the date of the Agreement. Mr. Gang Lai, Chairman and CEO of Universe Pharmaceuticals INC, commented, “We are excited to collaborate with JGSU...

HENDERSON, Nev., Dec. 29, 2021 (GLOBE NEWSWIRE) — P3 Health Partners Inc. (NASDAQ: PIII, or “P3”), a patient-centered and physician-led population health management company, today announced that its Chief Executive Officer, Dr. Sherif Abdou, and members of the P3 management team will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 5:15 p.m. (ET) / 2:15 p.m. (PT). The appearance will be webcast live and can be accessed in the Events & Presentations section of the P3 investor website. A replay will be available on the Company’s website following the event. To receive additional information, request an invitation or to schedule a one-on-one meeting, please contact your J.P. Morgan representative or the Company’s investor relations team at PIII@gatewayir.com. About P3 Health...

HOLLYWOOD, Fla., Dec. 29, 2021 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of compliance, technology, engineering, and environmental consulting solutions, announced today that it has been named the title sponsor for the Korn Ferry Tour’s Chicagoland area tournament hosted by the Western Golf Association. The NV5 Invitational will be played at The Glen Club in Glenview, IL from May 26-29, 2022 and will include a full field of 156 players competing for a $750,000 purse. All proceeds will support the Evans Scholars Foundation which provides full tuition and housing scholarships to caddies who demonstrate academic excellence and financial need. 2022 NV5 Investor DayNV5 will host an investor day at The Glen Club on Thursday, May 26, 2022 during the NV5 Invitational. NV5 will present its growth...

Company developing STAT-201 as a novel therapy for immune modulation in treating pediatric patients with Crohn’s Disease FORT COLLINS, Colo., Dec. 29, 2021 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced submission to the U.S. Food and Drug Administration (FDA) of its Phase 3 clinical trial protocol for STAT-201 in the treatment of pediatric Crohn’s Disease (CD). “Submitting our Phase 3 clinical trial protocol is a critical milestone in our development program,” said Michael K. Handley, President and Chief Executive Officer, Statera Biopharma. “In addition to the common GI symptoms, children with Crohn’s Disease often experience growth failure, malnutrition, delayed puberty,...

Lundin Energy AB (Lundin Energy) announces that the fourth quarterly dividend instalment of USD 0.45 per share will amount to SEK 4.09 per share, with a total amount of MSEK 1,164, corresponding to approximately MUSD 128. Information about the fourth quarterly instalment of the dividend:Amount per share(SEK) Total dividend amount (MSEK) Ex-dividend date Record date Expected payment date4.09 1,164 4 January 2022 5 January 2022 11 January 2022The Annual General Meeting of Lundin Energy held on 30 March 2021 resolved on a dividend for 2020 of USD 1.80 per share, to be paid in quarterly instalments of USD 0.45 per share. According to the dividend resolution, before payment, each quarterly dividend of USD 0.45 per share shall be converted into a SEK amount based on the USD to SEK exchange rate published by Sweden’s central bank (Riksbanken)...

All amounts expressed in US dollars unless stated otherwise NORTH MARA, Tanzania, Dec. 29, 2021 (GLOBE NEWSWIRE) —  Barrick Gold Corporation (NYSE:GOLD) (TSX:ABX) – Barrick’s North Mara mine today announced that it had achieved its commitment to bring the operation’s tailings storage facility’s (TSF) pond back within its permitted design capacity by the end of this year. Barrick made the commitment to the Tanzanian government when it took over control of the mine in September 2019, at a time when the country’s National Environment Management Council (NEMC) had closed down the TSF, then holding significantly more water than it should. The company’s chief operating officer for Africa and the Middle East, Willem Jacobs, described the achievement of the target as a huge milestone for North Mara and its team, who had made a herculean...